These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21894013)

  • 41. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.
    Alvarez-Lajonchere L; Dueñas-Carrera S
    Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
    Lauer GM
    J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
    Rollier CS; Paranhos-Baccala G; Verschoor EJ; Verstrepen BE; Drexhage JA; Fagrouch Z; Berland JL; Komurian-Pradel F; Duverger B; Himoudi N; Staib C; Meyr M; Whelan M; Whelan JA; Adams VC; Larrea E; Riezu JI; Lasarte JJ; Bartosch B; Cosset FL; Spaan WJ; Diepolder HM; Pape GR; Sutter G; Inchauspe G; Heeney JL
    Hepatology; 2007 Mar; 45(3):602-13. PubMed ID: 17326154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune and non-immune responses to hepatitis C virus infection.
    Sun J; Rajsbaum R; Yi M
    World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus-mediated modulation of cellular immunity.
    Brenndörfer ED; Sällberg M
    Arch Immunol Ther Exp (Warsz); 2012 Oct; 60(5):315-29. PubMed ID: 22911132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.
    Zhang S; Bakshi RK; Suneetha PV; Fytili P; Antunes DA; Vieira GF; Jacobs R; Klade CS; Manns MP; Kraft AR; Wedemeyer H; Schlaphoff V; Cornberg M
    J Virol; 2015 Aug; 89(16):8304-17. PubMed ID: 26041301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunopathogenesis of hepatitis C virus infection.
    Chang KM
    Clin Liver Dis; 2003 Feb; 7(1):89-105. PubMed ID: 12691460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection.
    Neumann-Haefelin C; Spangenberg HC; Blum HE; Thimme R
    World J Gastroenterol; 2007 Sep; 13(36):4839-47. PubMed ID: 17828815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
    Hartlage AS; Walker CM; Kapoor A
    J Virol; 2020 May; 94(10):. PubMed ID: 32102885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The development of therapeutic vaccine for hepatitis C virus].
    Kimura K; Kohara M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1451-7. PubMed ID: 23064054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD4+ T cell responses in hepatitis C virus infection.
    Semmo N; Klenerman P
    World J Gastroenterol; 2007 Sep; 13(36):4831-8. PubMed ID: 17828814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methods to Evaluate Novel Hepatitis C Virus Vaccines.
    Ahlén G; Frelin L
    Methods Mol Biol; 2016; 1403():221-44. PubMed ID: 27076133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adaptive immune responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Curr Top Microbiol Immunol; 2013; 369():243-62. PubMed ID: 23463204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C vaccines: Inducing and challenging memory T cells.
    Shiina M; Rehermann B
    Hepatology; 2006 Jun; 43(6):1395-8. PubMed ID: 16729320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients.
    Kamal SM; Amin A; Madwar M; Graham CS; He Q; Al Tawil A; Rasenack J; Nakano T; Robertson B; Ismail A; Koziel MJ
    J Virol; 2004 Nov; 78(22):12252-8. PubMed ID: 15507612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of immune responses in the pathogenesis of hepatitis C virus infection.
    Koziel MJ
    J Viral Hepat; 1997; 4 Suppl 2():31-41. PubMed ID: 9429208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of T cell immunity in hepatitis C virus infections.
    Claassen MA; Janssen HL; Boonstra A
    Curr Opin Virol; 2013 Aug; 3(4):461-7. PubMed ID: 23735335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?
    Neumann-Haefelin C
    Curr Opin Rheumatol; 2013 Jul; 25(4):426-33. PubMed ID: 23656712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic vaccines against hepatitis C virus.
    Xue J; Zhu H; Chen Z
    Infect Genet Evol; 2014 Mar; 22():120-9. PubMed ID: 24462908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
    Feinstone SM; Hu DJ; Major ME
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S25-32. PubMed ID: 22715210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.